27.1 C
Delhi
Sunday, October 1, 2023

Canada approves first bivalent Covid booster

Date:

Share post:

Ottawa: Health Canada authorized an adapted version of the Moderna Spikevax Covid-19 vaccine which targets the original SARS-CoV-2 virus from 2019 and the Omicron (BA.1) variant.

According to a statement issued by the agency on Thursday, this vaccine, known as a “bivalent” vaccine, is authorized for use as a booster dose in individuals 18 years of age or older.

This is the first bivalent Covid-19 vaccine authorized in Canada, said the agency, adding that the bivalent Moderna Spikevax booster is safe and effective with the same mild adverse reactions that resolved quickly.

Clinical trial results showed that a booster dose of the bivalent Moderna Spikevax vaccine triggers a strong immune response against both Omicron (BA.1) and the original SARS-CoV-2 virus strain, the agency added.

It was also found to generate a good immune response against the Omicron BA.4 and BA.5 subvariants, and is expected to extend the durability of protection, Health Canada said.

Related articles

NIA arrests accused from Manipur’s Churachandpur in Myanmar-Bangladesh transnational conspiracy case

On Saturday, September 30, the National Investigation Agency (NIA), arrested the accused, Seiminlun Gangte, in a case related...

Indore metro trial run flagged-off by MP CM Shivraj Chouhan

On Saturday, September 30, the Indore Metro trial run was successfully conducted after being flagged-off by Madhya Pradesh...

RBI extends deadline for returning Rs 2000 bank notes till Oct 7, 2023

New Delhi: The Reserve Bank of India (RBI) on Saturday extended the deadline for exchanging or depositing Rs...

Srinagar Court denies permission to PDP leader Waheed Parra to travel outside J&K

Srinagar: A Srinagar court rejected a plea by Peoples Democratic Party (PDP) youth president Waheed Parra, seeking permission...